DOI:
10.1055/s-00034914
Osteologie
LinksClose Window
References
Crawford JC, Johnston MA, Hancock ML. et al.
Enobosarm, a selective androgen receptor modulator (SARM), increases lean bodymass (LBM) in advanced nsclc patients; updated results of two pivotal, international phase 3 trials.
Support Care Cancer 2014;
22: S30-S31
We do not assume any responsibility for the contents of the web pages of other providers.